Aclipse Therapeutics

Aclipse Therapeutics

Pharmaceuticals, Civic Dr, Radnor Township, , 19087, Pennsylvania, 14343, United States, 1-10 Employees

aclipsetherapeutics.com

  • twitter
  • LinkedIn

Who is ACLIPSE THERAPEUTICS

Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk b...

Read More

map
  • 14343 Civic Dr, Radnor Township, Pennsylvania, 19087, United States Headquarters: 14343 Civic Dr, Radnor Township, Pennsylvania, 19087, United States
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 5122 | NAICS Code: 921120 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ACLIPSE THERAPEUTICS

Aclipse Therapeutics Org Chart and Mapping

Employees

Ning Shan

Chief Scientific Officer and Co-Founder

Brian Moyer

Vice President, Corporate Development and Finance

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aclipse Therapeutics

Answer: Aclipse Therapeutics's headquarters are located at Civic Dr, Radnor Township, , 19087, Pennsylvania, 14343, United States

Answer: Aclipse Therapeutics's official website is https://aclipsetherapeutics.com

Answer: Aclipse Therapeutics's revenue is Under $1 Million

Answer: Aclipse Therapeutics's SIC: 5122

Answer: Aclipse Therapeutics's NAICS: 921120

Answer: Aclipse Therapeutics has 1-10 employees

Answer: Aclipse Therapeutics is in Pharmaceuticals

Answer: Aclipse Therapeutics contact info: Phone number: Website: https://aclipsetherapeutics.com

Answer: Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access